Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Asterion Cannabis Inc. P.ASTR

Healthcare Cannabis
Asterion Cannabis Inc. is a Canadian medicinal cannabis company with a wholly owned Australian subsidiary. The company is focused on the future of precision agriculture and producing the highest quality, low cost, genetically uniform strains of cannabis.

Recent & Breaking News (:ASTR)

    The StockTalk Cannabis Report: Apr 10, 2020

    Dave Jackson April 10, 2020

    Canadian Cannabis Grows Business in Blossoming Australian Market

    Stockhouse Editorial April 6, 2020

    Asterion Announces $10 Million Private Placement

    Newsfile January 2, 2020

    Canadian Co. Awarded Medicinal Cannabis Licences from Australian Office of Drug Control

    Stockhouse Editorial December 23, 2019

    Asterion Awarded Medicinal Cannabis Licences from the Australian Office of Drug Control

    Newsfile December 23, 2019

    Asterion Cannabis Advances Medicinal Project Via New Agreement

    Stockhouse Editorial June 19, 2019

    Asterion Signs Equity Participation Agreement with Wellcamp Business Park Pty Ltd

    Stockhouse.com June 19, 2019

    Asterion Appoints John Wagner as Strategic Advisor

    Newsfile May 29, 2019

    Asterion to Hold 2019 Annual General Meeting and Corporate Presentations

    Canadian Press, with file by Stockhouse May 23, 2019

    Asterion Invited to Participate in the Cowen Toronto Cannabis Summit

    Canadian Press, with file by Stockhouse May 16, 2019

    Norton Rose Fulbright advises Asterion on $450 million medicinal cannabis project in Queensland

    Canadian Press, with file by Stockhouse May 8, 2019

    Asterion Announces $25 Million Private Placement

    Stockhouse.com May 6, 2019

    Asterion Signs Land Purchase Agreement for 75 Hectares of Land for its Queensland Medicinal Cannabis Facility

    Canadian Press, with file by Stockhouse April 24, 2019

    Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project

    Newsfile April 4, 2019

    Asterion Signs Research Agreement with the University of Queensland for Clonal Propagation of Cannabis Plants

    Stockhouse.com March 5, 2019

    Asterion Files an Application for Medicinal Cannabis Licenses From the Australian Office of Drug Control

    Stockhouse.com February 6, 2019

    Asterion Signs Heads of Agreement for the Acquisition and Preparation for Use of up to 90 Hectares of Land for its Queensland Production Facility

    Stockhouse.com February 4, 2019

    Asterion Announces $5 Million Private Placement

    Stockhouse.com January 24, 2019